Tenaya Therapeutics

Biotechnology
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.

$195.6M

Market Cap • 9/12/2025

2016

(9 years)

Founded

2021

(4 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium